MGMT promoter methylation in glioblastoma can influence temozolomide response, prognosis and treatment planning. This patient-friendly guide explains MGMT methylated vs unmethylated results, key questions for neuro-oncology, and how supportive Ayurveda may help strength, digestion, sleep and treatment tolerance alongside standard care.

IDH-mutant glioma is a molecularly defined brain tumor that often behaves differently from IDH-wildtype glioblastoma. This article explains what IDH mutation means, prognosis, vorasidenib eligibility, surgery, MRI follow-up, radiation, chemotherapy, recurrence risk, and how integrative Ayurvedic support may help patients improve strength, quality of life, and treatment tolerance under proper medical supervision.

Flat epithelial atypia on a breast biopsy does not always mean surgery is necessary. Learn when pure FEA may be safely monitored with imaging, when excision is recommended, how upgrade risk is assessed, and what radiology-pathology concordance means for your next steps.

Glioma vs glioblastoma explained in simple medical language. Learn the key differences in tumor grade, growth speed, symptoms, diagnosis, treatment, recurrence risk, survival outlook, and how supervised Ayurvedic support may help patients protect strength, quality of life, and treatment recovery.

Breast biopsy results explained in clear language for patients confused by ADH, ALH, FEA, papilloma, radial scar, complex sclerosing lesion, LCIS, or B3 breast lesions. Learn what these findings mean, when surgery or follow-up may be needed, and what questions to ask your breast specialist.

Glioblastoma survival rate varies by age, surgery, MGMT methylation, IDH status, treatment response, and overall health. This patient-focused guide explains life expectancy, survival statistics, recurrence, MRI changes, and treatment factors in a clear, medically reviewed format for families seeking realistic guidance.

Learn how to read PTH calcium vitamin D reports with simple, patient-friendly guidance on high PTH, calcium levels, vitamin D deficiency, corrected calcium, and common lab patterns. Understand what your results may mean, when to seek medical review, and how to discuss next steps with your doctor.

Can atypical hyperplasia turn into breast cancer? Learn why atypical hyperplasia is not breast cancer, how ADH and ALH increase future breast cancer risk, when surgery or MRI may be recommended, and what follow-up steps patients in the USA, UK, Australia, Singapore, and Canada should know.

High PTH normal calcium can feel confusing, but it is not one final diagnosis. It may be linked to low vitamin D, kidney changes, low calcium intake, poor absorption, urine calcium loss, or normocalcemic primary hyperparathyroidism. Learn what your result means, which tests to ask for, and when to see a specialist.